In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

INO Therapeutics LLC

Division of Ikaria Inc.
www.inotherapeutics.com

Latest From INO Therapeutics LLC

Ikaria Acquisition Diversifies And Strengthens Mallinckrodt’s Hospital Care Portfolio

But, with its $2.3 billion purchase price, Mallinckrodt is betting it can withstand a patent challenge to INOmax, an inhaled nitric oxide drug/device combo product, from an industrial gas company.

BioPharmaceutical United States

Deals Shaping The Medical Industry, December 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced October-November 2014.

BioPharmaceutical Medical Device

Phasing In A New Chief Executive At Shire: An Interview With Angus Russell

After announcing his retirement as CEO of Shire, effective next April, Angus Russell held a wide-ranging discussion with “The Pink Sheet” to explain why he is stepping down and why now is a good time for change at the specialty pharma.

BioPharmaceutical United States

Change At The Top For Shire: Bayer Exec To Succeed CEO Russell Next Year

Angus Russell, who transformed mid-sized specialty pharma Shire during his five-year-tenure, is retiring in April; Shire names Bayer executive Flemming Ornskov as his successor.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Cardiovascular
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ikaria Inc.
  • Senior Management
  • William D Cordivari, Global VP, Commercial Operations
  • Contact Info
  • INO Therapeutics LLC
    Phone: (908) 238-6600
    6 Rte. 173
    Clinton, NJ 08809
    USA
UsernamePublicRestriction

Register